TFIP11
Basic information
Region (hg38): 22:26491225-26512505
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFIP11 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 37 | 2 | 0 |
Variants in TFIP11
This is a list of pathogenic ClinVar variants found in the TFIP11 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-26491530-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
22-26491577-G-A | not specified | Uncertain significance (May 15, 2024) | ||
22-26492178-C-A | not specified | Uncertain significance (Sep 06, 2022) | ||
22-26492236-A-G | not specified | Uncertain significance (Jun 16, 2022) | ||
22-26492239-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
22-26492279-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
22-26492344-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
22-26494819-T-A | not specified | Uncertain significance (Jun 22, 2023) | ||
22-26494823-T-C | not specified | Uncertain significance (Jan 24, 2024) | ||
22-26494856-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
22-26494873-A-G | not specified | Uncertain significance (May 15, 2024) | ||
22-26494895-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
22-26494939-C-T | not specified | Uncertain significance (Mar 07, 2023) | ||
22-26496156-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
22-26496211-G-A | not specified | Uncertain significance (May 31, 2023) | ||
22-26496818-G-A | not specified | Uncertain significance (May 24, 2023) | ||
22-26496857-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
22-26498900-C-G | not specified | Uncertain significance (Dec 22, 2023) | ||
22-26498958-G-A | Likely benign (Mar 01, 2023) | |||
22-26498959-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
22-26498975-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
22-26499121-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
22-26499228-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
22-26499229-G-A | not specified | Uncertain significance (Sep 22, 2021) | ||
22-26499280-G-A | not specified | Uncertain significance (Jun 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TFIP11 | protein_coding | protein_coding | ENST00000407690 | 12 | 21281 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.66e-12 | 0.986 | 125625 | 0 | 123 | 125748 | 0.000489 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.35 | 415 | 500 | 0.830 | 0.0000302 | 5590 |
Missense in Polyphen | 84 | 127.24 | 0.66017 | 1484 | ||
Synonymous | -0.764 | 206 | 193 | 1.07 | 0.0000122 | 1516 |
Loss of Function | 2.48 | 26 | 43.7 | 0.595 | 0.00000221 | 465 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00123 | 0.00123 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000493 | 0.000484 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing, specifically in spliceosome disassembly during late-stage splicing events. Intron turnover seems to proceed through reactions in two lariat-intron associated complexes termed Intron Large (IL) and Intron Small (IS). In cooperation with DHX15 seems to mediate the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns. May play a role in the differentiation of ameloblasts and odontoblasts or in the forming of the enamel extracellular matrix. {ECO:0000269|PubMed:19103666}.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.875
- rvis_EVS
- -1.52
- rvis_percentile_EVS
- 3.42
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.922
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tfip11
- Phenotype
Gene ontology
- Biological process
- spliceosomal complex disassembly;mRNA splicing, via spliceosome;RNA processing;biomineral tissue development;negative regulation of protein complex assembly;protection from non-homologous end joining at telomere;negative regulation of protein binding;negative regulation of DNA ligase activity;negative regulation of double-strand break repair via nonhomologous end joining
- Cellular component
- nuclear chromosome, telomeric region;nucleoplasm;spliceosomal complex;nucleolus;cytoplasm;nuclear speck;extracellular matrix;U2-type post-mRNA release spliceosomal complex;catalytic step 2 spliceosome
- Molecular function
- nucleic acid binding;protein binding